Arcutis Biotherapeutics, Inc.
ARQT· Nasdaq
ARQTArcutis Biotherapeutics, Inc.
Filed May 6, 2021 · 10-Q · 36 days after period end · 0001628280-21-009291
| Metric | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|
| Net Income | -$36.04M | -$28.01M | -$6.66M |
| EPS Diluted | -$0.76 | -$1.15 | -$4.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcutis Biotherapeutics, Inc. · CIK 1787306 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 6, 2021 · 36 d after period end
